← Leaderboards
Cheuk Man Cherie Au
Arma Bio, Inc.
$1,611,960
Attributed
$1,611,960
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.2M · FY2024–25$2M$1.5M$1M$500K$0
'24
'25
Funding mix
By agency
NIH$1,611,960 · 2
By mechanism
R44$1,150,471 · 1
R42$461,489 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Rising Stars on “Enzalutamide”
- Remi Adelaiye-Ogala · State University Of New York At Buffalo$2,864,216
- Justin Michael Drake · Astrin Biosciences, Inc.$1,931,918
- Monika Joshi · Pennsylvania State Univ Hershey Med Ctr$1,466,430
- Feng Yang · Baylor College Of Medicine$1,431,666
- Grinu Mathew · University Of Nebraska Medical Center$1,379,946
- Pui-Kai Li · University Of California At Davis$1,169,912
Research focus
EnzalutamideIncidenceDrug KineticsEfficacy EvaluationAdvanced Prostate CancerGrowthAndrogen ReceptorDiagnosisDrug ResistanceEconomicsAndrogen Deprivation TherapyBiomarker DevelopmentAndrogen Independent Prostate CancerFoundationsCancer DiagnosisCancer EtiologyAndrogensDeprivationAndrogen AntagonistsCell NucleusCessation Of LifeEconomic BurdenClinical BiomarkersInhibitor
Grant awards (3)
Development of small molecule therapeutics targeting AR-V7 for prostate cancer$1,150,471
R44 · FY2025 · CA · contact PI
Development of small molecule therapeutics targeting AR-V7 for prostate cancer$406,489
R42 · FY2024 · CA · contact PI
Development of small molecule therapeutics targeting AR-V7 for prostate cancer$55,000
R42 · FY2024 · CA · contact PI